The largest database of trusted experimental protocols

Alliance q9 advanced

Manufactured by Uvitec
Sourced in United Kingdom

The Alliance Q9 Advanced is a high-performance laboratory equipment designed for various analytical applications. It features a robust and reliable construction, providing consistent and accurate results. The core function of the Alliance Q9 Advanced is to perform precise measurements and analyses, making it a versatile tool for scientific research and industrial testing.

Automatically generated - may contain errors

7 protocols using alliance q9 advanced

1

Characterization of Extracellular Vesicle Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were subjected to electrophoresis and immunoblotting as described in [29 (link)]. Primary antibodies used to characterize the EVs were against Alix (1:1000, Proteintech), Hsp70 (1:1000, Proteintech), Flotillin-2 (1:500, Fisher), CD9 (1:1000, Abcam), TGFβ (1:1000, Abcam) and β-actin (1:5000, Abcam) as loading control. We also evaluated the presence/absence of positive and negative EV markers in EVs and non-EV fractions (whole cell lysates, supernatant discarded after the last ultracentrifugation step (SP) and cell culture medium (CCM)) using the following primary antibodies as negative markers for EVs: Calnexin (1:1000, Novus Biologicals), Lamin A/C (1:500, Santa Cruz) and Histone3 (1:1000, Abcam). Secondary antibodies were anti-rabbit or anti-mouse IgG conjugated with alkaline phosphatase (1:4000, Sigma) except for CD9. For CD9 we used a secondary antibody conjugated to HRP-peroxidase (1:2500, Sigma) and chemiluminescent signal was obtained adding the SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific) according to the manufacturer instructions. CD9 images were acquired using an Alliance Q9 Advanced (Uvitec).
+ Open protocol
+ Expand
2

Immunoblotting for HEV Detection in Pets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples testing positive in rHEV EIAs were further assessed by immunoblots based on HEV-C1-P241 peptides as described in the supplementary material. Sera of dogs and cats were diluted 1:200 with 10% skim milk in PBS-T and added to membranes in the MiniProtean II Multiscreen Apparatus (BioRad, Hercules, USA) and incubated for one hour. Sample dilutions were then adjusted further (ranging from 1:200 to 1:400) to reduce background reactivity. Also, the membrane was exposed to 1:5000 diluted His-tag antibodies (Bio-Station, Hong Kong, China). The MiniProtean II Apparatus enables lane-by-lane separation of the immunoblot without cutting into strips. The membranes were washed for 30 mins and then incubated with species-specific HRP-conjugated secondary antibodies for 30 mins. The immunoreaction was detected using Alliance Q9 Advanced (Uvitec, Cambridge, UK) with WesternBright ECL HRP substrate (Advansta, San Jose, USA), with an exposure time between 60 and 90 sec.
+ Open protocol
+ Expand
3

Cerebellum Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total lysates from both control and VPA-treated male mice cerebella (n = 6) were obtained using RIPA buffer (50 mM Tris pH 7.4; 1% NP-40; 0.5% Na deoxycholate; 0.1% SDS; 150 mM NaCl; 1 mM EDTA) supplemented with protease inhibitor cocktail (P8340-5Ml, Sigma Aldrich), 0.5 mM Na3VO4 and 1 mM DTT. Lysates were incubated on ice for 20 min, briefly sonicated and centrifuged for 10 min at 13,000 rpm, 4 °C. Protein extracts were quantified by Bradford assay, resuspended at a final concentration of 20 μg and analysed by electrophoresis through 8–10% SDS-PAGE and blotted on a PVDF membrane (GE10600023, Amersham). Blots were firstly incubated with a blocking solution (5% non-fat dry milk in PBS) for 1 h at 25 °C and then with the following primary antibodies: mouse anti-β-ACTIN (sc-47778, Santa Cruz Biotechnology), rabbit anti-ROR-α (NR1F1, Novus), mouse anti-SHANK2 (NBP2-12914, Novus), rabbit anti-SHANK3 (NBP2-41171, Novus), mouse anti-GFAP (MAB-94373, Immunological Sciences). Antibodies were diluted 1:1000 in PBS/5% BSA solution and incubated overnight at 4 °C. After washing, blots were incubated with HRP-linked anti-rabbit and anti-mouse secondary antibodies (GE Healthcare) diluted 1:10,000 in PBS/5% non-fat dry milk. ECL signal was developed using Clarity Western ECL Blotting Substrate (Biorad) and acquired with the Alliance Q9 Advanced (Uvitec Cambridge).
+ Open protocol
+ Expand
4

Verifying Monoclonal Antibodies for Aspergillus Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting technique was used to verify whether these two monoclonal antibodies recognize the protein antigens or not. Aspergillus cell wall-related proteins (CWPs) samples with loading buffer were denatured at 95 °C for 10 min. The CWPs samples were separated in 10% SDS-PAGE and the immigration was completed in electrophoresis buffer (Tris-glycine-SDS). The CWPs were visualized by Coomassie Brilliant Blue (CBB) staining or transferred to a PVDF membrane in transfer buffer (Tris-glycine-methanol). The membrane was washed with Tris buffered saline (TBS) with 0.1% tween 20 and blocked with 5% trim milk for 1 h on the rocker. Afterward, the membrane was incubated with 1D2 or 4E4 supernatant (1:200) in 1% BSA at 4 °C overnight on the rocker. With 5 times (10 min each) washing, anti-mouse IgM-HRP secondary antibody (Abcam, Cambridge, UK) diluted at 1:10,000 was applied and incubated for 1 h on a rocker. After washing 5 times, the membrane was developed by incubation with chemiluminescent substrate (PerkinElmer, Waltham, MA, USA) and imaged by Alliance Q9 Advanced (Uvitec, Cambridge, UK).
+ Open protocol
+ Expand
5

Western Blot Analysis of CD279, pAKT, AKT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was extracted by using RIPA lysis buffer. The equal amount of protein samples was analyzed on 10% SDS-PAGE by mini-Protein III system (Bio-Rad, USA). The proteins were transferred to polyvinylidene fluoride membrane (GE Healthcare, USA). The membrane was probed with mouse anti-human CD279 antibody (BioRad), rabbit anti-human pAKT (Thr308) (Cell Signaling Technology), rabbit anti-human AKT (Cell Signaling Technology) and rabbit anti-human GAPDH antibody (BioRad). The signals were detected in different exposure times depending on each protein by horseradish peroxide (HRP) conjugated secondary antibodies and enhanced chemiluminescence substrate with Alliance Q9 Advanced (UVITEC, UK) or X-ray film. All original unmanipulated Western blot images were provided as the Supplementary Information.
+ Open protocol
+ Expand
6

Western Blot Protein Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in cold RIPA buffer (ab156034, Abcam) supplemented with protease and phosphatase inhibitors for 30 minutes in ice, and then centrifuged at 14,000 rpm for 20 minutes at 4°C. Supernatant was collected and protein quantification was performed using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). Equal amounts of protein lysates were loaded onto a 10% polyacrylamide gel, transferred onto nitrocellulose membranes, and incubated for 1 hour in 5% nonfat dry milk at room temperature. Primary antibodies are reported in Supplementary Table S3. Blotted membranes were developed by using Immobilon Western Chemiluminescent horseradish peroxidase (HRP) Substrate (Merck Millipore) and imaged with UVITEC Alliance Q9 Advanced (UVITEC Cambridge).
+ Open protocol
+ Expand
7

NFκB Binding Assay Using EMSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Electrophoretic mobility shift assay (EMSA) for NFκB was performed with the SYBR Green & SYPRO Ruby EMSA stain kit (E33075) according to the manufacturer's instructions. (catalog no. E33075, Thermo Fisher Scientific). Briefly, cells were lysed in ice-cold cytoplasmic Buffer A added with protease and phosphatase inhibitors for 10 minutes. Lysates were centrifugated at 2,000 × g for 5 minutes, supernatant discarded, and nuclear pellet was then lysed in 70 μL buffer C added with protease and phosphatase inhibitors for 30 minutes. For oligomer duplexes, 500 nmol/L of each of the two complementary oligonucleotides was mixed in a total volume of 100 μL of binding buffer. Complementary oligonucleotides were NFκB F: 5′- AGTTGAGGGGACTTTCCCAGGC-3′ and NFκB R: 5′-GCCTGGGAAAGTCCCCTCAACT-3′. After 10 minutes incubation at 95°C followed by additional 15 minutes at 70°C, samples were left to form oligomer duplexes while gradually cooling to room temperature. A total of 20 μg of nuclear extract were then added in binding buffer for additional 30 minutes at room temperature. Protein–DNA complexes were resolved by native 4% PAGE. Nucleic acid staining was achieved by incubating gel with SYBR Green EMSA gel stain solution in shaking for 20 minutes. Nucleic acids were visualized using UVITEC Alliance Q9 Advanced (UVITEC Cambridge).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!